Drug Name: Xenpozyme
Active Ingredient: Olipudase alfa
Indications: To treat Acid Sphingomyelinase Deficiency (ASD)
Approval Date: 8/31/2022
Company: Genzyme Corporation
Learn more: https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761261s000lbl.pdf